go-v.orgdoi

Thesaurus_PREVAC_WP1_Clinical data_v13.0.pdf

Institut national de la santé et de la recherche médicale, The London School of Hygiene, National Institute of Allergy and Infectious Diseases · Recherche Data Gouv France · 2026

  • DOI 10.57745/percut
  • Publisher OpenAlex
  • Type dataset
  • Issued 2026

Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.

Recherche Data Gouv France · OpenAlex · dataset · 2026

Abstract

Through the PREVAC/PREVAC-UP project, the following data are generated : clinical data (WP1); immunological data (WP1, WP2, and WP3); retention questionnaire data (WP5). Please find below the description of the concerned WPs : - WP1 : Randomized, placebo-controlled trial, in adults and in children, conducted by the Partnership for Research on Ebola Vaccinations (PREVAC) consortium in West Africa to evaluate the safety and immediate (1 year) and long-term (5-year) immune response of three vaccine strategies : Ad26.ZEBOV followed by MVA-BN-Filo 56 days later (Ad26/MVA, Janssen Vaccine), rVSVΔG-ZEBOV-GP (rVSV, Merck Vaccine), and rVSV followed by rVSV 56 days later.

ClinicalTrials.gov ID: NCT02876328. WP1 associated data : Clinical data and immunological data (FANG and Luminex data). Database organization description documents available in the WP1 DOBDs. - WP2: Immunological substudy analyzes the immunogenicity of the vaccine strategies used in the PREVAC trial (WP1) and focus on T cell responses induced by the vaccines in adult population and on their middle and long-term persistence until 5 years after vaccination. WP2 associated data : immunological data.

Database organization description document available in the WP2 DOBD. - WP3: Malaria and helminth infections substudy determines whether the rate of decline in antibody titer to the EBOLA virus glycoprotein induced by immunization with vaccine strategies used in the PREVAC trial (WP1) is influenced by exposure to malaria or helminth infections, measured by serology, over a period of 4-5 years. WP3 associated data: immunological data.

Database organization description document available in the WP3 DOBD. - WP5: Empirical Research on Barriers and Facilitators to Study Retention in the PREVAC trial (WP1) identifies multi-level determinants of participant retention in the PREVAC trial to develop recommendations that will benefit future clinical research in resource limited settings affected by Ebola and other infectious diseases. WP5 associated clinical data: retention questionnaire completed by participants available in the WP1 clinical data. Database organization description document available in the WP1 DOBD.

Open the resolved locator · 10.57745/percut

Metadata licence: OpenAlex metadata (CC0)

Registry
OpenAlex DOI index + API
Fetched
2026-11-19 20:53 UTC
Cache state
not cached yet (bulk-index+openalex)
Locator
https://entrepot.recherche.data.gouv.fr/file.xhtml
Metadata licence
OpenAlex metadata (CC0)
Scope
Metadata as returned by the resolver; abstracts are never generated here.